These graphs compare the performance of the biotech stocks for all of 2025 using the BioWorld Stock Indicator and the Nasdaq Biotech Index.

Year-to-date money raised in public, private and other financings of biopharma companies.

Total raised in public, private and other financings of biopharma companies, comparing 2019-2025.

Biopharma money raised to-date and by month in 2025, including public, private and other financings.

A preview of the next edition of BioWorld, Aug. 8, 2025

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Cybin, Fibrogen, Jazz, OS Therapies, Valneva.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Absci, Almirall, Coherus, Cormedix, Intas, Keros, Melinta, Novo Nordisk, Prothena.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Assembly, Braintree, Eledon, Eli Lilly, OS, Palisade, Sellas, Spinogenix.

Biopharmas raising money in public or private financings, including: Adma, Belite, Chai, Faron, Maxwell, Processa, Sana, Snipr Biome, Strand.

New hires and promotions in the biopharma industry, including: Cullinan, Keros, Therabene.